TP53 and neuroendocrine carcinoma: Frequent mutations in the TP53 gene was confirmed in a recent report, in which next-generation sequencing of 50 cancer-related genes in 23 NEC tumors showed several different mutations, but with the presence of TP53 mutation in the majority of tumors.